Effectiveness of ustekinumab dose escalation in Crohn’s disease patients with insufficient response to standard‐dose subcutaneous maintenance therapy
Uri Kopylov, David Drobne, Darragh Storan, Davide De Marco, Eran Zittan(Emek Medical Center), Nicola Imperatore, Nikolas Plevris, Waqqas Afif, Marieke Pierik(Maastricht University Medical Centre), Denis Franchimont(McGill University Health Centre), Glen Doherty, Iria Bastón‐Rey, Fabiana Castiglione, Frank Hoentjen(Radboud University Nijmegen), Anneline Cremer, Marie Truyens, Shaji Sebastian(University of Hull), Yago González Lama, Claire Liefferinckx, Manuel Barreiro‐de Acosta(Universidade de Santiago de Compostela), Vince Biemans(Radboud University Nijmegen), Shomron Ben‐Horin, Zuzana Zelinková, Bar‐Gil Shitrit Ariella, Željko Krznarić(University Hospital Centre Zagreb), Jurij Hanžel, Charlie W. Lees(University of Edinburgh), Richard Harris(Southampton City Council), Cyrielle Gilletta, Klaudia Farkas, Tamás Molnár, Sally Myers(University of Hull), Roni Weisshof, Triana Lobatón, Stephan R. Vavricka(Triemli Hospital), Viktor Domislović
Cited by 80
Related Papers
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
|Nature|2012|4.8k
ESPEN guidelines on nutrition in cancer patients
|Clinical Nutrition|2016|3k
Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci
|Nature Genetics|2010|2.6k
Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease
|Nature Genetics|2017|1.5k
ESPEN practical guideline: Clinical Nutrition in cancer
|Clinical Nutrition|2021|1.4k